Base de dados : MEDLINE
Pesquisa : D26.670 [Categoria DeCS]
Referências encontradas : 4583 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 459 ir para página                         

  1 / 4583 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28743244
[Au] Autor:Bazargan M; Smith J; Yazdanshenas H; Movassaghi M; Martins D; Orum G
[Ad] Endereço:Charles R. Drew University of Medicine & Science, 1731 East 120th Street, Los Angeles, CA, 90005, USA. mobazarg@cdrewu.edu.
[Ti] Título:Non-adherence to medication regimens among older African-American adults.
[So] Source:BMC Geriatr;17(1):163, 2017 Jul 25.
[Is] ISSN:1471-2318
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Despite concerns about racial differences on adherence to prescribed medication rigimens among older adults, current information about nonadherence among underserved elderly African Americans with co-morbidities is limited. This study examines the association between adherence to drug regimens and an array of medication-related factors, including polypharmacy, medication regimen complexity, use of Potentially Inappropriate Medications (PIM), and knowledge about the therapeutic purpose and instructions of medication use. METHODS: Four-hundred African Americans, aged 65 years and older, were recruited from South Los Angeles. Structured, face-to-face interviews and visual inspection of participants' medications were conducted. From the medication container labels, information including strength of the drug, expiration date, instructions, and special warnings were recorded. The Medication Regimen Complexity Index (MRCI) was measured to quantify multiple features of drug regimen complexity. The Beers Criteria was used to measure the PIM use. RESULTS: Participants reported taking an average of 5.7 prescription drugs. Over 56% could not identify the purpose of at least one of their medications. Only two-thirds knew dosage regimen of their medications. Thirty-five percent of participants indicated that they purposely had skipped taking at least one of their medications within last three days. Only 8% of participants admitted that they forgot to take their medications. The results of multivariate analysis showed that co-payment for drugs, memory deficits, MRCI, and medication-related knowledge were all associated with adherence to dosage regimen of medications. Participants with a higher level of knowledge about therapeutic purpose and knowledge about dosage regimen of their medications were seven times (CI: 4.2-10.8) more likely to adhere to frequency and dose of medications. Participants with a low complexity index were two times (CI: 1.1-3.9) more likely to adhere to the dosage regimen of their medications, compared with participants with high drug regimen complexity index. CONCLUSIONS: While other studies have documented that non-adherence remains an important issue among older adults, our study shows that for underserved elderly African Americans, these issues are particularly striking. A periodic comprehensive assessment of all medications that they use remains a critical initial step to identify medication related issues. Assessment of their disease and medication related knowledge (e.g., therapeutic purposes, side-effects, special instructions, etc.) and their ability to follow complicated medication regimens and modification of their drug regimens requires inter-professional collaboration.
[Mh] Termos MeSH primário: Afroamericanos/psicologia
Conhecimentos, Atitudes e Prática em Saúde
Alfabetização em Saúde/métodos
Adesão à Medicação/psicologia
[Mh] Termos MeSH secundário: Idoso
Idoso de 80 Anos ou mais
Estudos Transversais
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/diagnóstico
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/epidemiologia
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/prevenção & controle
Feminino
Hospitalização/tendências
Seres Humanos
Masculino
Educação de Pacientes como Assunto/métodos
Polimedicação
Lista de Medicamentos Potencialmente Inapropriados/tendências
Medicamentos sob Prescrição/efeitos adversos
Estados Unidos/epidemiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Prescription Drugs)
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180305
[Lr] Data última revisão:
180305
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170727
[St] Status:MEDLINE
[do] DOI:10.1186/s12877-017-0558-5


  2 / 4583 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29352280
[Au] Autor:Fernandez-Navarro P; Aragones MT; Ley V
[Ad] Endereço:Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain.
[Ti] Título:Leisure-time physical activity and prevalence of non-communicable pathologies and prescription medication in Spain.
[So] Source:PLoS One;13(1):e0191542, 2018.
[Is] ISSN:1932-6203
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Our aims were to describe physical activity (PA) behaviour in Spain and to examine its association with the prevalence of some of the major non-communicable diseases and with the use of prescription medication. Individualized secondary data retrieved from the 2014 European Health Interview Survey (EHIS) for Spain were used to conduct a cross-sectional epidemiological study (n = 18926). PA was assessed by two different measures: a specific designed variable for EHIS and a leisure time PA frequency-based query of the national survey. Diseases analyzed were hypertension, diabetes, hypercholesterolemia, depression and anxiety. The use of prescription medication was also included in the study. Weighted percentages were computed and contingency tables were calculated to describe PA by levels of the traits and sociodemographic characteristics. Chi-square test was used to compare percentages between groups and weighted logistic regression models were used to assess the relationship between PA and the prevalence of the disease. About 73% of the Spanish population performs no PA at all or only occasionally during their leisure time, and only one third meets minimum PA international guidelines (≥ 150min/week). Men are considerably more active than women and less PA is observed as the education level decreases and as age increases. The risk of the diseases evaluated was up to three times higher among inactive individuals. This study provides national population-based estimations highlighting the impact of PA in Spain, not only in the prevalence of some of the major non-communicable diseases but also in reducing prescription medication, and the potential sex and socioeconomic influence.
[Mh] Termos MeSH primário: Exercício
Atividades de Lazer
Doenças não Transmissíveis/epidemiologia
Medicamentos sob Prescrição
[Mh] Termos MeSH secundário: Adolescente
Adulto
Idoso
Estudos Transversais
Feminino
Inquéritos Epidemiológicos
Seres Humanos
Modelos Logísticos
Masculino
Meia-Idade
Prevalência
Fatores de Risco
Estilo de Vida Sedentário
Fatores Sexuais
Fatores Socioeconômicos
Espanha/epidemiologia
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Nome de substância:
0 (Prescription Drugs)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180226
[Lr] Data última revisão:
180226
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:180121
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pone.0191542


  3 / 4583 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28464141
[Au] Autor:Larkin I; Ang D; Steinhart J; Chao M; Patterson M; Sah S; Wu T; Schoenbaum M; Hutchins D; Brennan T; Loewenstein G
[Ad] Endereço:University of California, Los Angeles.
[Ti] Título:Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing.
[So] Source:JAMA;317(17):1785-1795, 2017 May 02.
[Is] ISSN:1538-3598
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Importance: In an effort to regulate physician conflicts of interest, some US academic medical centers (AMCs) enacted policies restricting pharmaceutical representative sales visits to physicians (known as detailing) between 2006 and 2012. Little is known about the effect of these policies on physician prescribing. Objective: To analyze the association between detailing policies enacted at AMCs and physician prescribing of actively detailed and not detailed drugs. Design, Setting, and Participants: The study used a difference-in-differences multivariable regression analysis to compare changes in prescribing by physicians before and after implementation of detailing policies at AMCs in 5 states (California, Illinois, Massachusetts, Pennsylvania, and New York) that made up the intervention group with changes in prescribing by a matched control group of similar physicians not subject to a detailing policy. Exposures: Academic medical center implementation of policies regulating pharmaceutical salesperson visits to attending physicians. Main Outcomes and Measures: The monthly within-drug class market share of prescriptions written by an individual physician for detailed and nondetailed drugs in 8 drug classes (lipid-lowering drugs, gastroesophageal reflux disease drugs, diabetes drugs, antihypertensive drugs, hypnotic drugs approved for the treatment of insomnia [sleep aids], attention-deficit/hyperactivity disorder drugs, antidepressant drugs, and antipsychotic drugs) comparing the 10- to 36-month period before implementation of the detailing policies with the 12- to 36-month period after implementation, depending on data availability. Results: The analysis included 16 121 483 prescriptions written between January 2006 and June 2012 by 2126 attending physicians at the 19 intervention group AMCs and by 24 593 matched control group physicians. The sample mean market share at the physician-drug-month level for detailed and nondetailed drugs prior to enactment of policies was 19.3% and 14.2%, respectively. Exposure to an AMC detailing policy was associated with a decrease in the market share of detailed drugs of 1.67 percentage points (95% CI, -2.18 to -1.18 percentage points; P < .001) and an increase in the market share of nondetailed drugs of 0.84 percentage points (95% CI, 0.54 to 1.14 percentage points; P < .001). Associations were statistically significant for 6 of 8 study drug classes for detailed drugs (lipid-lowering drugs, gastroesophageal reflux disease drugs, antihypertensive drugs, sleep aids, attention-deficit/hyperactivity disorder drugs, and antidepressant drugs) and for 9 of the 19 AMCs that implemented policies. Eleven of the 19 AMCs regulated salesperson gifts to physicians, restricted salesperson access to facilities, and incorporated explicit enforcement mechanisms. For 8 of these 11 AMCs, there was a significant change in prescribing. In contrast, there was a significant change at only 1 of 8 AMCs that did not enact policies in all 3 areas. Conclusions and Relevance: Implementation of policies at AMCs that restricted pharmaceutical detailing between 2006 and 2012 was associated with modest but significant reductions in prescribing of detailed drugs across 6 of 8 major drug classes; however, changes were not seen in all of the AMCs that enacted policies.
[Mh] Termos MeSH primário: Centros Médicos Acadêmicos/estatística & dados numéricos
Conflito de Interesses
Indústria Farmacêutica
Prescrições de Medicamentos/estatística & dados numéricos
Política Organizacional
Médicos/estatística & dados numéricos
Medicamentos sob Prescrição/uso terapêutico
[Mh] Termos MeSH secundário: Anticolesterolemiantes/uso terapêutico
Antidepressivos/uso terapêutico
Anti-Hipertensivos/uso terapêutico
Antipsicóticos/uso terapêutico
California
Fármacos Cardiovasculares/uso terapêutico
Seres Humanos
Hipnóticos e Sedativos/uso terapêutico
Hipoglicemiantes/uso terapêutico
Illinois
Relações Interprofissionais
Massachusetts
New York
Pennsylvania
Análise de Regressão
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Anticholesteremic Agents); 0 (Antidepressive Agents); 0 (Antihypertensive Agents); 0 (Antipsychotic Agents); 0 (Cardiovascular Agents); 0 (Hypnotics and Sedatives); 0 (Hypoglycemic Agents); 0 (Prescription Drugs)
[Em] Mês de entrada:1706
[Cu] Atualização por classe:180227
[Lr] Data última revisão:
180227
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170503
[St] Status:MEDLINE
[do] DOI:10.1001/jama.2017.4039


  4 / 4583 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29361661
[Au] Autor:White RS; Thomson Reuters Accelus.
[Ti] Título:Pharmaceuticals and Medical Devices: FDA Oversight.
[So] Source:Issue Brief Health Policy Track Serv;2017:1-43, 2017 Dec 26.
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Aprovação de Drogas/organização & administração
Legislação de Medicamentos
United States Food and Drug Administration
[Mh] Termos MeSH secundário: Sistemas de Notificação de Reações Adversas a Medicamentos
Contaminação de Medicamentos
Rotulagem de Medicamentos
Drogas em Investigação
Farmacoeconomia
Sistemas Eletrônicos de Liberação de Nicotina
Terapia Genética
Regulamentação Governamental
Seres Humanos
Disponibilidade de Medicamentos Via Internet
Medicamentos sob Prescrição/efeitos adversos
Medicamentos sob Prescrição/economia
Medicamentos sob Prescrição/uso terapêutico
Regeneração
Produtos do Tabaco/legislação & jurisprudência
Estados Unidos
United States Food and Drug Administration/legislação & jurisprudência
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Drugs, Investigational); 0 (Prescription Drugs)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180219
[Lr] Data última revisão:
180219
[Sb] Subgrupo de revista:T
[Da] Data de entrada para processamento:180124
[St] Status:MEDLINE


  5 / 4583 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29361660
[Au] Autor:Steiner DJ; Thomson Reuters Accelus.
[Ti] Título:Pharmaceuticals and Medical Devices: Business Practices.
[So] Source:Issue Brief Health Policy Track Serv;2017:1-38, 2017 Dec 26.
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Indústria Farmacêutica/organização & administração
Farmacoeconomia
Legislação de Medicamentos
Medicamentos sob Prescrição/economia
[Mh] Termos MeSH secundário: Analgésicos Opioides
Leis Antitruste
Suplementos Nutricionais
Custos de Medicamentos
Controle de Medicamentos e Entorpecentes/legislação & jurisprudência
Medicamentos Genéricos
Epinefrina/economia
Epinefrina/uso terapêutico
Fraude
Seres Humanos
Prescrição Inadequada
Marketing de Serviços de Saúde
Medicaid
Medicare
Uso Off-Label
Patentes como Assunto
Desvio de Medicamentos sob Prescrição
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Analgesics, Opioid); 0 (Drugs, Generic); 0 (Prescription Drugs); YKH834O4BH (Epinephrine)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180219
[Lr] Data última revisão:
180219
[Sb] Subgrupo de revista:T
[Da] Data de entrada para processamento:180124
[St] Status:MEDLINE


  6 / 4583 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29361657
[Au] Autor:Steiner DJ; Thomson Reuters Accelus.
[Ti] Título:Pharmaceuticals and Medical Devices: Cost Savings.
[So] Source:Issue Brief Health Policy Track Serv;2017:1-31, 2017 Dec 26.
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Custos de Medicamentos
Indústria Farmacêutica/economia
Farmacoeconomia/organização & administração
Medicamentos sob Prescrição/economia
[Mh] Termos MeSH secundário: Canadá
Comércio/economia
Redução de Custos
Dedutíveis e Cosseguros
Revelação
Aprovação de Drogas
Custos de Medicamentos/legislação & jurisprudência
Medicamentos Genéricos/economia
Competição Econômica
Farmacoeconomia/legislação & jurisprudência
Epinefrina/economia
Seres Humanos
Adesão à Medicação
Conduta do Tratamento Medicamentoso/economia
Medicamentos sem Prescrição/economia
Farmácias/economia
Equivalência Terapêutica
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Drugs, Generic); 0 (Nonprescription Drugs); 0 (Prescription Drugs); YKH834O4BH (Epinephrine)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180219
[Lr] Data última revisão:
180219
[Sb] Subgrupo de revista:T
[Da] Data de entrada para processamento:180124
[St] Status:MEDLINE


  7 / 4583 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Colômbia
Texto completo SciELO Saúde Pública
[PMID]:28453154
[Au] Autor:Quijano-Prieto DM; Orozco-Díaz JG; Holguín-Hernández E
[Ad] Endereço:Maestría en Medio Ambiente y Desarrollo, Universidad Nacional de Colombia, Bogotá, Colombia, dmquijanop@unal.edu.co.
[Ti] Título:[Patients' knowledge and practices about unconsumed drugs disposal. An Approach to Ecopharmacovigilance].
[Ti] Título:Conocimientos y prácticas de pacientes sobre disposición de medicamentos no consumidos. Aproximación a la ecofarmacovigilancia..
[So] Source:Rev Salud Publica (Bogota);18(1):61-71, 2016 Feb.
[Is] ISSN:0124-0064
[Cp] País de publicação:Colombia
[La] Idioma:spa
[Ab] Resumo:Objective To describe knowledge, attitudes and practices about remaining drugs (RD) and expired drugs (ED) disposal. Method Descriptive study in 392 patients at a hospital in Bogotá, Colombia. Results Participants were 17 to 86 years old. 66.1% of them had RD, 31.4 % were nervous system drugs (according to Anatomical Therapeutic Chemical classification of WHO). 25.8 % of people dispose of RD in common waste (CW) and 64.0 % dispose of ED in CW. 17.4 % think RD, and 62.5 % think ED should be thrown away like CW. 4.9% of people think RD, and 6.6 % think ED should be thrown away in specialized places. 92.4 % people don't know about DRP nor 86.7 % about "Puntos Azules"; 94.6 % would like more information. 79.1 % think that throwing away drugs can affect health and, 88.8 %, the environment. Conclusions Most participants dispose of drugs inappropriately. They think that it is wrong and this can damage the environment and health. There is an interest in being informed. This reveals an area of possible work in awareness, information and education from pharmacovigilance about this subject for the benefit of the population.
[Mh] Termos MeSH primário: Poluentes Ambientais
Conhecimentos, Atitudes e Prática em Saúde
Medicamentos sob Prescrição
[Mh] Termos MeSH secundário: Adolescente
Adulto
Idoso
Idoso de 80 Anos ou mais
Colômbia
Feminino
Seres Humanos
Masculino
Meia-Idade
Farmacovigilância
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Environmental Pollutants); 0 (Prescription Drugs)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180215
[Lr] Data última revisão:
180215
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170429
[St] Status:MEDLINE


  8 / 4583 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29351178
[Au] Autor:Welton JM; Kleiner C; Valdez C; Richardson S; Boyle K; Lucas E
[Ad] Endereço:Author Affiliations: Professor and Senior Scientist (Dr Welton), Health Systems Research, University of Colorado College of Nursing, Aurora; Research Scientist, Nursing Outcomes, Research, and EBP (Dr Kleiner), Biostatistician, Department of Patient Safety and Quality (Ms Valdez), Professional Development Specialist, Nursing Education, Research, and AHA (Ms Richardson), and Chief Nursing Officer (Dr Boyle), Denver Health, Colorado; Research Assistant and Graduate Student (Mr Lucas), MPH Program, University of Colorado School of Public Health, Aurora.
[Ti] Título:Using Time-Referenced Data to Assess Medication Administration Performance and Quality.
[So] Source:J Nurs Adm;48(2):100-106, 2018 Feb.
[Is] ISSN:1539-0721
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: This study tests the feasibility of using a large (big) clinical data set to test the ability to extract time-referenced data related to medication administration to identify late doses and as-needed (PRN) administration patterns by RNs in an inpatient setting. METHODS: The study is a secondary analysis of a set of data using bar-code medication administration time stamps (n = 3043812) for 50883 patients admitted to a single, urban, 525-bed hospital in 11 inpatient units by 714 nurses between April 1, 2013, and March 31, 2015. RESULTS: The large majority of scheduled medications (43.3%) were administered between 9 to 10 AM and 9 to 10 PM accounting for the most amount of delayed doses. On average, patients received 8.9 medications per day, and nurses administered 19.7 medications per shift. The average full-time nurse administered 3414 medications per year. CONCLUSIONS: The findings support use of time-referenced data to identify clinical processes and performance in administering scheduled and PRN medications.
[Mh] Termos MeSH primário: Esquema de Medicação
Pacientes Internados/estatística & dados numéricos
Erros de Medicação/estatística & dados numéricos
Sistemas de Medicação no Hospital/estatística & dados numéricos
Enfermeiras e Enfermeiros/estatística & dados numéricos
Medicamentos sob Prescrição/administração & dosagem
[Mh] Termos MeSH secundário: Adulto
Feminino
Hospitais Urbanos/estatística & dados numéricos
Seres Humanos
Masculino
Meia-Idade
Fatores de Tempo
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Prescription Drugs)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180205
[Lr] Data última revisão:
180205
[Sb] Subgrupo de revista:AIM; IM; N
[Da] Data de entrada para processamento:180120
[St] Status:MEDLINE
[do] DOI:10.1097/NNA.0000000000000580


  9 / 4583 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29281576
[Au] Autor:Dave CV; Hartzema A; Kesselheim AS
[Ad] Endereço:Brigham and Women's Hospital, Boston, MA.
[Ti] Título:Prices of Generic Drugs Associated with Numbers of Manufacturers.
[So] Source:N Engl J Med;377(26):2597-2598, 2017 12 28.
[Is] ISSN:1533-4406
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Custos de Medicamentos
Medicamentos Genéricos/economia
Medicamentos sob Prescrição/economia
[Mh] Termos MeSH secundário: Estados Unidos
[Pt] Tipo de publicação:LETTER
[Nm] Nome de substância:
0 (Drugs, Generic); 0 (Prescription Drugs)
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180115
[Lr] Data última revisão:
180115
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:171228
[St] Status:MEDLINE
[do] DOI:10.1056/NEJMc1711899


  10 / 4583 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29258478
[Au] Autor:McLay JS; Izzati N; Pallivalapila AR; Shetty A; Pande B; Rore C; Al Hail M; Stewart D
[Ad] Endereço:The Division of Applied Health Sciences, The University of Aberdeen, Aberdeen, UK. j.mclay@abdn.ac.uk.
[Ti] Título:Pregnancy, prescription medicines and the potential risk of herb-drug interactions: a cross-sectional survey.
[So] Source:BMC Complement Altern Med;17(1):543, 2017 Dec 19.
[Is] ISSN:1472-6882
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Pregnant women are routinely prescribed medicines while self-medicating with herbal natural products to treat predominantly pregnancy related conditions. The aim of this study was to assess the potential for herb-drug interactions (HDIs) in pregnant women and to explore possible herb-drug interactions and their potential clinical significance. METHODS: A cross-sectional survey of women during early pregnancy or immediately postpartum in North-East Scotland. Outcome measures included; Prescription medicines use excluding vitamins and potential HDIs assessed using Natural Medicines Comprehensive Database. RESULTS: The survey was completed by 889 respondents (73% response rate). 45.3% (403) reported the use of at least one prescription medicine, excluding vitamins. Of those taking prescription medicines, 44.9% (181) also reported concurrent use of at least one HNP (Range 1-12). A total of 91 different prescription medicines were reported by respondents using HNPs. Of those taking prescription medicines, 44.9% (181) also reported concurrent use of at least one HNP (Range 1-12). Thirty-four herb-drug interactions were identified in 23 (12.7%) women with the potential to increase the risk of postpartum haemorrhage, alter maternal haemodynamics, and enhance maternal/fetal CNS depression. Almost all were rated as moderate (93.9%), one as a potentially major (ginger and nifedipine) and only one minor (ondansetron and chamomile). CONCLUSION: Almost half of pregnant women in this study were prescribed medicines excluding vitamins and minerals and almost half of these used HNPs. Potential moderate to severe HDIs were identified in an eighth of the study cohort. Healthcare professionals should be aware that the concurrent use of HNPs and prescription medicines during pregnancy is common and carries potential risks.
[Mh] Termos MeSH primário: Interações Ervas-Drogas
Medicamentos sem Prescrição
Extratos Vegetais
Medicamentos sob Prescrição
[Mh] Termos MeSH secundário: Adolescente
Adulto
Estudos Transversais
Feminino
Seres Humanos
Medicamentos sem Prescrição/efeitos adversos
Medicamentos sem Prescrição/uso terapêutico
Fitoterapia/estatística & dados numéricos
Extratos Vegetais/efeitos adversos
Extratos Vegetais/uso terapêutico
Gravidez
Medicamentos sob Prescrição/efeitos adversos
Medicamentos sob Prescrição/uso terapêutico
Inquéritos e Questionários
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Nonprescription Drugs); 0 (Plant Extracts); 0 (Prescription Drugs)
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180108
[Lr] Data última revisão:
180108
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171221
[St] Status:MEDLINE
[do] DOI:10.1186/s12906-017-2052-1



página 1 de 459 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde